We used a series of gene disruptions and gene replacements to mutagenically characterize 30 kilobases of DNA in the erythromycin resistance gene (ermE) region of the Saccharopolyspora erythraea chromosome. Five previously undiscovered loci involved in the biosynthesis of erythromycin were found, eryBI, eryBII, eryCl, eryCII, and eryH; and three known loci, eryAl, eryG, and ermE, were -further characterized. The new Ery phenotype, EryH, was marked by (i) the accumulation of the intermediate 6-deoxyerythronolide B (DEB), suggesting a defect in the operation of the C-6 hydroxylase system, and (ii) a block in the synthesis or addition reactions for the first sugar group. Analyses of ermE mutants indicated that erinE is the only gene required for resistance to erythromycin, and that it is not required for production of the intermediate erythronolide B (EB) or for conversion of the intermediate 3-a-mycarosyl erythronolide B (MEB) to erythromycin. Mutations in the eryB and eryC loci were similar to previously reported chemically induced eryB and eryC mutations blocking synthesis or attachment of the two erythromycin sugar groups. Insertion mutations in eryAI, the macrolactone synthetase, defined the largest (at least 9-kilobase) transcription unit of the cluster. These mutants help to define the physical organization of the erythromycin gene cluster, and the eryH mutants provide a source for the production of the intermediate DEB.
Erythormycin A is a medically important macrolide antibiotic produced by the gram-positive, sporeforming bacterium Saccharopolyspora erythraea (formerly Streptomyces erythraeus NRRL 2338) (29) . As is the case for other antibiotic-producing organisms, the genes for the biosynthesis of erythromycin (ery) are thought to be clustered about the gene for resistance to erythromycin, ermE (22, 27, 29) ; however, much remains to be learned about the organization and location of the many individual genes predicted to be involved in the pathway (6, 18) .
The ermE gene was originally cloned by Thompson et al. (24) and later sequenced by Uchiyama and Weisblum (25) ; its promoter and the promoter of an adjacent upstream open reading frame were characterized by Bibb et al. (3, 4) . The adjacent open reading frame has since been sequenced by Dhillon et al. (7) , inactivated by gene disruption, and found to be involved in erythromycin biosynthesis as an eryC-type gene. Independently, the open reading frame was shown by Vara et al. (25a) to be an eryC-type gene through complementation of the eryC160 allele, and we obtained the same results as Dhillion et al. (7) by using linker insertion mutagenesis (see below). Other landmarks in the ery gene cluster are (i) eryG, the O-methyltransferase located 6.5 kilobase pairs (kb) downstream of the ermE promoter region (1Sa, 28) ; (ii) eryAI, the macrolactone synthetase, a large locus beginning 3 kp upstream of eryG (J. Tuan, J. M. Weber, M. Staver, J. 0. Leung, and L. Katz, Gene, in press); and (iii) the eryB25, eryB26, and eryD24 genes, mapped within an 18-kb region upstream of ermE (25a) .
Despite this recent progress, large areas of the ermE region were functionally uncharacterized prior to this study, and the C-6 hydroxylase (see Fig. 3 , step 2) was genetically uncharacterized owing to a lack of mutations in this step. In the work reported here we investigated the function of these uncharacterized regions between the known genes by using * Corresponding author.
S. erythraea and two methods we developed for this purpose which make further use of the pIJ702-based plasmid integration and excision systemn (27, 28) . The first approach, scanning gene disruption, was modeled after mutational cloning described by Chater and Bruton (5) for the analysis of the methylenomycin gene cluster in Streptomyces coelicolor and it is analogous to a similar system described for Saccharomyces cerevisiae (20) . The second approach, linker scanning, was modeled after linker insertion (8, 15, 23) , which has been used in both procaryotic and eucaryotic systems for mutational analysis of complex genetic loci.
We report the creation of a set of mutations covering a region of approximately 30 kb and the identification of five new loci involved in synthesis or attachment of the erythromycin sugars, eryBl, eryBII, eryCl, eryClI, and eryH. Mutations in eryH block both the synthesis or attachment of mycarose (as in an eryB mutant) and the previous step, the C-6 hydroxylation reaction. We also present additional information on the previously identified genes in the cluster, including the first mutational characterization of the ermE gene in S. erythraea.
MATERIALS AND METHODS
Bacterial strains, cloning vectors, and growth media. Wildtype derivatives of S. erythraea were used in this study. The host strains for integrative transformation were S. erythraea UW110 (met4 leu-18 rif-63) and UW267 (arg-6 eryB25). Cross-feeding and precursor feeding test strains were as follows: eryA, UW352 (arg-14 eryA34); eryB, UW267 (arg-6 eryB25); eryC, UW254 (eryC160); and eryD, UW280 (arg-8 eryD24), described previously (29) . The host strain for autonomously replicating pIJ702 derivatives was Streptomyces lividans TK21 (kindly provided by D. A. Hopwood, John Innes Institute, Norwich, United Kingdom). The host strain for Escherichia coli-derived plasmid vectors was E. coli DH5a (Bethesda Research Laboratories, Inc., Gaithersburg, Md.) or JM109 (31) . The erythromycin assay strain Bacillus Gene disruption pMW37-18a AI-18 pMW27 +1. 9 Gene disruption pMW40-15 Al-1 pMW27 +1. 75 Gene disruption pMW42-9 BII-9 pMW27 +0. 5 Gene disruption pMW42-14 CII-14 pMW27 +0. 9 Gene disruption pMW42-15 CII-15 pMW27 +0. 9 Gene disruption pMW42-32 +-32 pMW27 +0.98 w.t. insertion pMW42-36 CII-36 pMW27 +0. 9 Gene disruption pMW44a +/G-44 pGM420 +5 Staver, Abbott Laboratories; a description of the isolation of ermE-containing cosmids is described elsewhere (Tuan et al., in press). A list of plasmids mentioned in this report is presented in Table 1. S. erythraea strains were grown in liquid culture in 50-ml tryptic soy broth (Difco Laboratories, Detroit, Mich.) in 500-ml shake flasks at 32°C. For solid cultures, plates of tryptic soy broth-2% Bacto-Agar (Difco) were used for cross-feeding and precursor feeding experiments, or R2T2 agar plates (28) were used for regeneration of mycelia from protoplasts or as a general sporulation medium. Thiostrepton was added at 5 ,ug/ml (liquid culture) or 10 ,ug/ml (solid culture) for selection of S. erythraea transformants. Streptomyces lividans was handled under conditions specified by Hopwood et al. (10) Fig. 2A and B) . A more precise mapping of the insertion site was obtained through analysis of the size of the junction fragments and through restriction and Southern analyses of the plasmid.
Construction of other integrative plasmids for gene disruption. In the course of this analysis, several other integrative plasmids were constructed. pMW11-A was used for insertional inactivation of the eryG gene, based on the experiment described previously (28) . It was constructed from the 0.4-kb PstI fragment isolated from pGM403 (described below) cloned into the unique PstI site of pIJ702.
pMW37-18, pMW37-17, and pMW37-3 were constructed for the initial gene disruption experiments in eryAI; their construction and characterization are described elsewhere (Tuan et al., in press) and described in this report with permission from the authors.
pMW44 is an integrative plasmid that contains the +/ G-44 insert (see Fig. 4 Fig. 4 , sites 1 to 21) containing the eryG gene, which was purified by gel electrophoresis. pBR322 was digested with EcoRI and BamHI, and the resulting DNA was ligated to the 4.5-kb EcoRI-BamHI fragment containing eryG (see Fig. 4 , sites 11 to 21), obtained by digesting the purified 9.1-kb HindIIIEcoRI fragment with BamHI. The resulting plasmid, pGM403, contains the eryG gene cloned into pBR322.
pGM406 contains the +-406 insert (see Fig. 4 ); it was constructed from KpnI-digested pGM403 that had been treated with calf intestinal alkaline' phosphatase and ligated to Kpn-I-digested pIJ702. pGM449 was constructed from pGM403 digested with XhoI and treated with DNA polymerase I (Klenow fragment) to create blunt ends. The resulting DNA was then digested with EcoRI, and the 1.8-kb fragment that was produced was purified by gel electrophoresis. pIJ487 (26) was digested with BamHI, treated with Klenow fragment to form blunt ends, and then digested with EcoRI. The 6.2-kb fragment that was produced was ligated to the 1.8-kb fragment from pGM403 to create pGM449.
Linker scanning. Linker scanning in S. erythraea combines the in vitro mutagenic technique of linker mutagenesis (8) with a method for gene replacement. In S. erythraea, gene replacement can be performed by exploiting the pIJ702 based integration-excision system (28) .
Plasmids were constructed of 6-to 14-kb DNA fragments from the ermE region of the S. erythraea chromosome cloned into pUC18 (Bethesda Research Laboratories). The plasmids were treated with DNaseI to generate single-cut, full-length linear plasmid DNA whose ends were made blunt through treatment with DNA polymerase I (Klenow fragment). Phosphorylated BglII linkers (New England BioLabs) 15°C overnight, and transformed into E. coli JM109 cells selecting for ampicillin resistance. Plasmids with new BglII sites located within the S. erythraea DNA were identified, subcloned into pGM420 (Fig. 1B) , and integratively transformed into S. erythraea UWllO. Purified integrated transformants were physically characterized by chromosomal Southern analyses to confirm the presence of new DNA sequences in the chromosome (see Fig. 2C and D) and biochemically analyzed to determine the erythromycin phenotype.
Integrated strains were passed nonselectively through a cycle of growth and sporulation, allowing for spontaneous excision of the integrated vector. Depending on the site of the second crossover with respect to the mutation, excision of the plasmid led to the stable incorporation of the mutation into the host genome or reconstruction of the original wild-type sequence. Chromosomal Southern analysis of the excised transformant derivatives was used to physically identify the strains in which gene replacement had occurred (see Fig. 2C and D).
Techniques for the characterization of the Ery-phenotype. Bioassays for erythromycin and the erythromycin precursor feeding technique are described by Weber et al. (29) . Identification of erythromycin pathway intermediates by thinlayer chromatography and the cross-feeding technique for characterization of S. erythraea mutants are described by Weber et al. (29) (also see Fig. 5 and 6 ). RESULTS Mutational analysis of the ermE region. Scanning gene disruption in S. erythraea is based on the ability of pIJ702-derived plasmids bearing segments of S. erythraea chromosomal DNA to integrate into the chromosome by singlereciprocal (Campbell) recombination (27, 28) . In principle, if the cloned chromosomal DNA is internal to a transcription unit, integration of the plasmid should be mutagenic (an example is presented in Fig. 2A and B) . If it overlaps a transcriptional boundary, insertion is predicted to be nonmutagenic.
Linker scanning in S. erythraea relies on the pIJ702-based gene replacement technique (described below) and the linker method for in vitro mutagenesis of cloned DNA (8) . It was used for the introduction of in vitro-mutagenized DNA sequences into the chromosome in place of the wild-type allele at its natural location. Variations on the method of gene replacement have been described for other antibioticproducing species by Piret and Chater (16) To characterize gene replacement in S. erythraea, we analyzed total DNA during three stages of the process: before and after integration of the plasmid, and after excision of the plasmid. An example involving the eryCI16 mutation is presented (Fig. 2D) . The predicted transformant structures fell into four classes (Fig. 2C) . Classes I and II resulted from single reciprocal crossovers on opposite sides of the linker insertion; classes III and IV indicated the operation of a homogenetization (gene conversion) process functioning in both directions, as well as integration. Analysis of the phenotypes of integrative intermediates in gene replacement indicated whether the transcript was entirely contained within the cloned fragment or overlapped one or both ends of the insert.
We found that the percentage and class of homogenotes varied depending on the mutation. In the experiment described, three of four transformants were homogenotes, although only one representative of the two different classes is shown (Fig. 2D) . Another type of transformant was sometimes observed that contained tandem duplications of the plasmid in the chromosome; however, this phenomenon has not yet been further characterized.
In the final stage of gene replacement, the vector sequences were allowed to spontaneously excise from the chromosome. This process occurred when the cells were grown through a cycle of sporulation in the absence of drug selection. These strains were usually found by screening 100 to 200 colonies for the loss of the plasmid-associated thiostrepton resistance and then by Southern analysis to show loss of the plasmid and introduction of a new restriction site into the chromosome.
To simplify the handling of larger numbers of mutagenic plasmids needed for scanning mutagenesis, we developed plasmids pMW27 and pGM420, which could be used as high-copy plasmids in E. coli and Streptomyces spp. and could integrate at high frequency in S. erythraea ( Fig. 1A and B). The efficiency of integrative transformation was such that integration could be achieved with plasmids bearing as little as 300 base pairs (bp) of homology to the S. erythraea chromosome. This improved the odds of identifying small transcriptional units in the ermE region by scanning gene disruption.
Although both gene disruption and gene replacement in S. erythraea utilize pIJ702-based vectors, little is known about the cause of the instability of pIJ702 in S. erythraea. To determine whether the pIJ702 replicon was required for integrative transformation, we transformed S. erythraea with pIJ702-based bifunctional plasmids isolated from E. coli which contained S. erythraea DNA inserted into the pIJ702 replicon at the BamHI site (12, 13) . In parallel, transformations were performed with pIJ702-based plasmids carrying S. erythraea DNA at BglII, the usual cloning site. Transformants reproducibly appeared with plasmids carrying BglIH inserts at frequencies between 103 and 104 primary transformants per ,ug of DNA, but never appeared with plasmids carrying BamHI inserts. We speculate that the pIJ702 replicon must function at least partially to obtain primary transformants and that perhaps it is able to be maintained relatively stably in the chromosome of this species because its replication functions are defective in S. erythraea.
The eryAI locus. eryA mutants are blocked early in the biosynthetic pathway (Fig. 3) , either in the synthesis of the erythronolide ring (6-deoxyerythronolide B [DEB]) or in the synthesis of its precursors, methylmalonyl coenzyme A or propionyl coenzyme A (6, 29) . The enzymes involved in the later steps of the pathway, however, are functional in eryA strains, as inferred from the results of cross-feeding and precursor-feeding experiments (29) in which the intermediates erythronolide B (EB) and 3-a-mycarosyl erythronolide B (MEB) (Fig. 3) are converted into erythromycin.
The eryAI locus was first defined through complementation of the eryAI941 mutation and through gene disruption experiments in the area around eryAI941, showing the minimum size of the locus to be 5 kb (Tuan et al., in press). We have continued the gene disruption analyses and in so doing have found the left end (closest to ermE) of eryAI but not the right end of the locus after analysis of an additional and pMW55-26 transformant strains. Purified DNA from the S. erythraea parent strain UW110 and the pMW55-26 transformant strain was digested with BamHI or NcoI, and DNA fragments were separated on a 0.7% agarose gel and transferred to nylon sheets by a modification of the method of Southern (21) . Nylon sheets were probed with the radioactively labeled insert DNA, which was removed from pMW55-26 by digestion of the plasmid with PstI and SstI. The bands showing hybridization correspond to sizes expected from the structural analysis of vector-chromosome junction bands as diagrammed in panel A. Lanes 1: BamHI-digested parental DNA; 2, BamHI-cut transformant DNA; 3, NcoI-digested parental DNA; 4, NcoI-digested transformant DNA. (C) Integration of recombinant plasmid pGM16 into the S. erythraea chromosome. The recombinant plasmid derived from pGM420 is shown carrying the eryCIH6 BgIII-linker mutation (bold bar above box; G = BglII site) on a 5.5-kb fragment of S. erythraea DNA (circle with box, indicating the eryCI16 clone with the arrow indicating the postulated complete transcription unit and direction of transcription) (7). The homologous wild-type site on the S. erythraea chromosome is also shown (Fig. 4) . The Sau3A insert Al-1 carried by pMW40-15 extended from a point 0.1 kb to the left of site 27 to approximately 1.75 kb to the right of site 27. This insert overlapped with inserts AI-17 and AI-18; however, it did not overlap with insert CII-36, which was the first insertion mutation to the left of eryAI that did not confer the EryA phenotype.
We expected to be able to find the right boundary of the eryAI locus by using the same strategy as we used to find the left boundary. We therefore scanned a 5-kb region, AI-48 (Fig. 4) , overlapping the right end of the previous eryAI boundary (J. Tuan et al., in press) by 1 kb. Forty integrated transformants were obtained and analyzed in this region, and all were eryA mutants. Our results indicate that eryA genes extend throughout this 9-kb region, and we are in the process of analyzing the adjacent sequences to find the end of the cluster.
Genes for formation or attachment of the erythromycin sugars: eryBI, eryBII, eryCI, and eryCII. To analyze the function of DNA sequences in the 2.3-kb EcoRI fragment overlapping the left end of eryAI (Fig. 4 , sites 21 to 27), we made random plasmid insertions into this region of strain UW110. The integrated strains fell into three phenotypic classes; EryB, EryC, and wild type. The EryB and EryC mutants have been described previously (29) ; they are postulated to carry defects in the biosynthesis or attachment of the two erythromycin sugar groups, mycarose and desosamine, respectively. This is inferred from the results of precursor accumulation and feeding experiments (29) . Similar types of experiments were performed on the insertion mutants produced in this study ( Fig. 5 and 6 ). We noticed however, that the EryC phentotype varies slightly from one eryC mutant to the next in the proportions of the two precursors, EB and MEB, that are accumulated.
To map the inserts of six representative plasmids in this region, we digested them to release the insert, blotted them by the method of Southern (21) , and probed them with the right and left NcoI subfragments of the 2.3-kb EcoRI fragment. The right probe hybridized to the three EryC inserts (CII-14, CII-15, and CII-36; all were 0.9 kb), and the two wild-type inserts (+-32, 0.98 kb; +-5, 0.81 kb). The left probe hybridized to the EryB insert (BII-9, 0.5 kb) and the wild-type inserts. The mutants were further analyzed through Southern analysis of chromosomal DNA to show that they actually carried the integrated plasmid through recombination at the site of homology (data not shown).
These results indicated that an eryC locus, herein designated eryCII, is completely contained within this 2.3-kb EcoRI fragment; it falls to the left of the Al-1 fragment and to the right of or partially overlapping fragment +-32. An eryB locus designated eryBII is also possibly located here, to the left of the CII-36 fragment but probably overlapping the left end of fragment +-32. We infer from the location of fragment +-32 that eryBII and eryCII are likely to be on separate transcripts.
Scanning further to the left of site 17 by gene disruption, we found another eryB insertion mutant, eryBIIJ9. The 0.55-kb insert from this plasmid mapped to the region overlapping site 20, which is about 0.5 kb to the right of the transcription start point of eryG (28) . We do not know yet whether the eryBII9 and eryBIII9 mutations are in the same or adjacent transcripts. A second pair of eryB and eryC loci were found in the intermediate vicinity of ermE. The second eryC locus, designated eryCI, was identified by linker scanning in the region immediately upstream (to the left) of the ermE gene (Fig. 4) . This locus had been partially sequenced in an earlier study; however, no function had been determined for the gene (4) . In the present study three eryCI mutants were generated by gene replacement and characterized. The first mutation, eryCI8, was a deletion extending from 50 bp upstream of site 0 to 400 bp farther upstream (Fig. 4) . The second and third mutations, eryCIH6 and eryCIH8, were BglII linker insertions at sites 500 and 850 bp upstream of site 0, respectively. In standard biochemical and morphological analyses, the eryCII phenotype was indistinguishable from eryCI. Our results are consistent with results of experiments performed independently by (i) Dhillon et al. (7), who identified the eryCI gene through gene disruption, and (ii) by Vara et al. (25a) , who identified the eryCI gene through complementation of the eryCI60 allele.
The second eryB locus, eryBI, was identified by scanning gene disruption in the region immediately downstream of ermE. The mutagenic plasmid pMW55-27 carried an insert (Fig. 4, BI-27 ) of approximately 0.8 kb that overlapped a pair of adjacent KpnI sites (Fig. 4, sites 3 and 4) separated by approximately 0.68 kb. Although this insertion fell very close to the 3' end of ermE, it did not affect the resistance of the strain to erythromycin.
Our results therefore indicate that there are at least two eryB and eryC loci and that they are significantly separated from one another in the ery gene cluster.
Insertions in the eryG region. We repeated the construction of the insertion mutation which was originally used to describe the eryG gene (Fig. 4, eryGIl) (28) and confirmed that a strain bearing it accumulates erythromycin C (Fig. 5 , Er-C). In addition, four new insertions in the eryG region were produced and analyzed to further characterize the eryG transcript.
One insert, +-406 (Fig. 4) , was 4.5 kb, covered the entire eryG region between sites 12 and 21, and resulted in the wild-type, erythromycin-accumulating phenotype. Another insert, +-3, was 0.5 kb and mapped to the 2-kb interval on the left side (Fig. 4 , ermE-proximal side) between sites 12 and 16; it was also wild-type. The two other sites partially overlapped eryG: +IG-449 was between sites 18 and 21, and +/G-44 was between sites 18 and 30. Strains bearing these mutations had a leaky EryG phenotype indicated as +/G; the ery+/G449 strain accumulated slightly more erythromycin C than erythromycin A when grown in TSB; the ery+lG44 strain accumulated mostly erythromycin A but showed higher levels of accumulation of erythromycin C than did the wild-type strain.
Since the +-406 insertion was wild type, at least one end of the eryG transcript must be contained in the 4.5-kb region between sites 12 and 21 (Fig. 4) . The wild-type +-3 insertion narrowed the left end down to the 2-kb interval between sites 12 and 16. This was consistent with previously reported RNA studies showing the 3' end of eryG to fall in this region (28) . The +/G-449 and +/G-44 insertions were more complex. Because these strains did produce significant levels of erythromycin A, the inserts did overlap the 5' end of at least one eryG transcript; nevertheless, a significant disruption in the efficiency of conversion of erythromycin C to erythromycin A was created. This was especially true for the ery+/G449 mutation. It is possible that another transcript covering eryG begins to the right of site 17. We are in the process of investigating this phenomenon further.
Mutants bearing defects in a new locus, eryH, accumulate DEB. To test for the presence of ery genes between eryG and ermE, the 5-kb fragment between sites 1 and 11 (Fig. 4) was analyzed by gene disruption. Two Ery-strains were identi-J. BACTERIOL. fied, with a new phenotype. One was integrated with a plasmid carrying a 0.37-kb insert that mapped just to the left of site 9 (Fig. 4 and 2A and 3) ; the other carried a 0.43-kb insert that mapped between sites 10 and 12, overlapping site 11 (Fig. 4) .
Strains with mutations in this locus were characterized by (Fig. 5) . In precursorfeeding experiments, both mutant strains were unable to convert exogenously supplied DEB, as expected, but they were also unable to convert exogenously supplied EB, indicating that they were also defective in some aspect of the synthesis or attachment of mycarose to DEB (also true for eryB mutants). Cross-feeding experiments did not distinguish between these mutants and eryB mutants: both types of strains cross-secreted to eryA mutants, cross-converted with eryC mutants, and did not cross-feed with other eryB or eryD mutants (Fig. 6) .
The biochemical data indicated that strains bearing mutations in this locus are defective in two consecutive steps of the biosynthetic pathway; first in the C-6 hydroxylation at step 2, and second in the addition or synthesis of mycarose to the macrolide ring at step 3 of the pathway (Fig. 3 ). This new type of mutant is being given the designation EryH. The two alleles described previously are eryH26 and eryH33, bearing the 0.37-and 0.43-kb inserts, respectively. In related linker-scanning experiments with the BamHI fragment between sites 6 and 11 (Fig. 4) , a third eryH mutation was found, eryH434. Like the previously described eryH mutants, the eryH434 mutant was also blocked in steps 2 and 3 of the pathway (Fig. 3) .
For these experiments plasmid pGM434 was constructed, which contained an in vitro-mutagenized derivative of the BamHI fragment (sites 6 to 11) cloned into the BglII site of pGM420, and transformed into strain UW110. Three classes of transformants, I, II, and V, were obtained and analyzed (see convention established in previous example [ Fig. 2C]) . The results showed class I integrants to be Ery+ and class II integrants to be Ery-. Recall that in the previous example, both integrated classes I and II were Ery+, presumably because one good copy of the eryCI gene was present in the chromosome of each class. The results obtained in this example with the eryH434 mutation, however, indicate that the cloned fragment contained only the left end of the transcript. When this type of plasmid integrates, one complete transcript (to the right of the vector sequences) and one incomplete transcript (to the left of the vector sequences) are generated. Only when the crossover causes the mutation to fall into the right side with the complete gene (class II) will integration be mutagenic. In the case of eryH434, the mutant phenotype occurred only when the linker mutation fell to the right (class II). The complete transcription unit, therefore, is predicted to overlap the right side of the cloned DNA (site 11) and extend to the left into the cloned fragment at least as far as the BglII linker (H-434) but not as far as site 6.
In summary, the combined results from two mutagenic plasmid insertions and a single gene replacement suggest that the eryH locus begins on the left side in the interval between site 6 and the H-434 insert and ends to the right of site 11 before reaching the right end of the +-3 insertion (Fig.  4) . Further support for this interpretation was obtained through another linker insertion, H-436, which is 1 kb to the left of H-434 and close to the right of site 6. It was found to have no effect on erythromycin biosynthesis. This mutation therefore lies beyond the left end of the eryH locus. ermE mutants are highly sensitive to erythromycin A. In previous studies the ermE gene was cloned from S. erythraea and shown to confer resistance to erythromycin in Streptomyces lividans (24) . The ermE gene has been tran-scriptionally characterized as well (4, 25) . In this study we conducted experiments to determine whether ermE is the only determinant for erythromycin resistance in S. erythraea and whether expression of ermE is required for expression of the biosynthetic pathway genes. To do this, ermE mutants were created in an eryB25 (EB-accumulating) background (strain UW267; see Materials and Methods) by gene replacement of the wild-type allele with either the ermE7 mutation, a 0.8-kb deletion from site 1 to the right into ermE, or the ermE14 mutation, a BglIl linker insertion at a site approximately 100 bp to the right of site 0. Strains carrying the eryB25 mutation alone were resistant up to 10 mg of erythromycin A per ml; however, double mutants carrying both eryB25 and either ermE7 and ermE14 were resistant up to only 10 jig of erythromycin A per ml. The ermE mutants, therefore, were 1,000-fold more sensitive to erythromycin A than the parent strain was. Although these ermE eryB mutants were now highly sensitive to erythromycin, they (i) continued to produce and accumulate the precursor EB and (ii) were now highly sensitive to the precursor MEB at levels as low as 10 ,ug/ml, presumably because they were able to convert this intermediate to erythromycin. On the basis of the results described above, we suggest that ermE is the only constitutively functioning erythomycin resistance gene in S. erythraea and that it is not essential for expression of most, if not all, of the erythromycin biosynthetic genes (only step 3, EB to MEB, remains to be tested).
Phenotypically silent mutations 5' of ermE. To further investigate the function of sequences 5' of ermE (to the left in Fig. 4) , we analyzed the 10-kb BglII fragment between sites -9 and -14 by linker scanning. Although seven linker insertion-deletion mutants were constructed in this interval, none of them were found to be defective in erythromycin biosynthesis. The 3-kb interval between kb -7.5 and -10.7 was particularly well characterized in that it contained one 2-kb deletion (+-457) and four linker insertions separated from each other by less than 500 bp (+-458, +-459, +-460, and +-461). This interval therefore represents the left end or a significant gap in the ery gene cluster. Vara et al. (25a) suggest from the results of complementation experiments that at least one other ery gene defined by the eryB25 and eryB26 alleles maps farther to the left of this region. Our results based on two additional deletions to the left (+454 and +450) suggest that this gene is not between kb -12 and -12.5 (+454) or at kb -15.2 (+-450). The eryB gene of Vara et al. therefore must be in the spaces between these mutations or farther to the left.
No other phenotypes were associated with insertions in this region, indicating that this region does not contain genes involved in primary metabolism, morphological differentiation, or pigment production. DISCUSSION The principal contribution of this study was to identify and map new genes in the region close to the erythromycin resistance gene (ermE) of S. erythraea. To do this we used pIJ702-based gene disruption (28) and developed a linker insertion technique, also by using pIJ702-based vectors, to selectively mutagenize an area of approximately 30 kb. We found five new loci, eryBI, eryBII, eryCI, eryCII, and eryH, all involved in some aspect of deoxysugar biosynthesis or attachment to the macrolactone ring. Despite their common functions, they were not clustered, except for eryBI and eryCII, which were adjacent but appear to be on separate transcription units. This is in contrast to the clustered arrangement for the genes required for macrolactone-ring synthesis (eryAI genes), which appear to be in a single transcription unit of more than 9 kb.
We compared our new mutants from gene disruption and gene replacement with the previously described mutants from chemical treatment and/or UV irradiation (29; J. M. Weber, Ph.D. dissertation, University of Wisconsin, Madison, 1983) and found them to be phenotypically similar. We have since learned that the eryCl and eryCII loci described in this report are actually the sites of two of the five previously described eryC mutations, eryC160 (also referred to as ery-60 or eryCI-60) and eryC210 (also referred to as ery-210), respectively (7, 25a, 29; Weber, Ph.D. dissertation). The eryC160 allele has been recently shown by Vara et al. (25a) to be complemented by DNA from the eryCI locus; and we have recently observed complementation of the eryC210 allele by the 5.3-kb XhoI fragment (Fig. 4) The mapping of the previously described eryB alleles is addressed in the recent work of Vara et al. (25a) . Although two eryB alleles, eryB25 and eryB26, were mapped to the region within 18 kb upstream of ermE, two others, eryB40 and eryB46, were not mapped there, but also did not map to the eryBI or eryBII loci described in this report. Our data show that there are at least two separate eryB loci; however,
we have yet to determine whether they are the sites of any previously described eryB alleles.
In addition to the known eryB and eryC strains, we found mutants with mutations in a new locus, designated eryH. The eryH mutants were actually blocked in two apparently unrelated steps of the pathway: (i) in the biosynthesis or attachment of mycarose to the macrolactone ring (like eryB mutants), and (ii) in the C-6 hydroxylation of DEB to form EB. This unusual phenotype could result from our insertion mutations if they disrupted a regulatory gene affecting both steps 2 and 3 ( Fig. 3 ) of the pathway, or if the insertion mutations had a polar effect through disruption of an operon containing genes for both steps 2 and 3. Since the C-6 hydroxylase has been recently purified (19) , it should soon be possible from the amino acid sequence to generate synthetic oligonucleotide probes and screen the region directly for the C-6 hydroxylase gene.
Erythromycin resistance is critical to the survival of S.
erythraea. An important finding of ours was that the ermE gene is the only constitutively expressed determinant of this phenotype in S. erythraea. We also show that the ermE gene product does not play a structural or regulatory role in the production of erythromycin from the intermediate MEB, and it is not involved in the operation of the early pathway either, up to synthesis of the intermediate EB.
Apparently not all antibiotic producers are the same in this regard. It is known, for example, that the producer of tylosin, Streptomyces fradiae, carries at least three genes which can confer resistance to tylosin (2, 32) and that other antibiotic resistance genes may be involved in regulatory or enzymatic functions required for antibiotic biosynthesis (9) .
In summary, we have more clearly defined the organization and function of a 30-kb region of the S. erythraea chromosome around the ermE gene. We found eight loci contained within a 22-kb portion of this region, extending from 1 kb upstream of ermE to 21 kb downstream. Starting to the far right, eryAI was the largest transcription unit identified so far, at 9 kb. It is known to be transcribed from right to left, convergent with ermE (Fig. 4) 172, 1990 on October 29, 2017 by guest http://jb.asm.org/ Downloaded from press). The next three loci, eryCII, eryBII, and eryG, were smaller and appear to be on separate transcripts; eryG transcription is also convergent with ermE (28) . In the 5-kb interval between eryG and ermE, only the eryH locus has been identified so far, and it appears to contain a regulatory gene or an operon of at least two structural biosynthetic genes involved in steps 2 and 3 of the pathway (Fig. 3) . Approximately 3 kb-of adjacent DNA in this region is still mutagenically uncharacterized. Farther to the left are the eryBI, ermE, and eryCI genes. The ermE gene and eryCI have been shown in previous work to be adjacent to one another and transcribed divergently (4) . To the left of eryCl is a 6-kb region that has not been mutagenically characterized, although it is said to contain at least the eryD24 allele (25a). This area is followed by a 3-to 8-kb region which does not contain genes involved in erythromycin biosynthesis and represents either a gap in the ery cluster or the left end of the cluster. We expect that even more ery genes may be found as the region is more completely mutagenized, for example, the regions between ermE and eryG, and the sequences at both ends of the cluster. We expect that this can be reliably accomplished in our future studies by using the gene disruption and linker scanning techniques that we have developed and described in this report.
